on the contrary , with cytotoxic regimens not linked to a high frequency of secondary leukemia such as cmf ( cyclophosphamide , methotrexate , 5-fluorouracil ) used in ovarian or breast cancer , mcv increase was moderate .
C0950521
cmf
C0025677
methotrexate